Theradaptive to Expand Global Clinical Trials After Receiving Full Ethics Approval in Australia for OsteoAdapt SP

Theradaptive can now enroll patients at each site in Australia listed with Bellberry as part of its global clinical study for OsteoAdapt SP. FREDERICK, Md., Feb. 27, 2024 /PRNewswire-PRWeb/ -- Theradaptive, a market leader in targeted regenerative therapeutics, has received full ethics...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI Source Type: news